Oral Micronized Progesterone Cost in North Carolina (2026)

At a glance
- Average NC cash-pay price (generic) / $45 per month
- Brand Prometrium list price / $180 per month
- Compounded progesterone (503A pharmacy) / approximately $25 per month
- NC Medicaid coverage for HRT use / not covered (type 2 diabetes indications only)
- Telehealth prescribing in NC / yes, fully legal
- Dosage form / oral capsule, 100 mg or 200 mg
- Typical schedule / nightly continuous or 12-day cyclic
- Prescription status / prescription only
- FDA-approved indications / secondary amenorrhea and endometrial hyperplasia prevention
- Compounded progesterone legality in NC / yes, through 503A pharmacies
What Oral Micronized Progesterone Costs at NC Pharmacies Right Now
The average cash-pay price for a 30-day supply of generic oral micronized progesterone at North Carolina retail pharmacies sits at $45 in 2026. Brand-name Prometrium carries a manufacturer list price of $180 per month, though almost no one pays that figure out of pocket because generics became widely available after the original FDA-approved formulation lost exclusivity. Pricing can swing by $10 to $20 depending on the chain. Costco and independent pharmacies in Raleigh, Charlotte, and the Triangle tend to price at the lower end, while smaller rural pharmacies sometimes charge more due to lower dispensing volume.
A 100 mg capsule and a 200 mg capsule often cost the same per unit at retail, which matters for women on cyclic dosing (200 mg nightly for 12 days per cycle) versus continuous dosing (100 mg nightly). The PEPI trial established that oral micronized progesterone at 200 mg for 12 days per cycle effectively opposed estrogen-induced endometrial hyperplasia with fewer side effects than medroxyprogesterone acetate [1]. That cyclic regimen uses fewer capsules per month, so the actual monthly cost can drop to $18 to $25 cash-pay. Continuous dosing at 100 mg nightly requires 30 capsules, landing at the full $45 average.
The Endocrine Society's 2015 clinical practice guideline on menopausal hormone therapy recommends progesterone co-administration for any woman with an intact uterus receiving estrogen, making the cost of progesterone a recurring line item for most HRT patients in North Carolina.
NC Medicaid Coverage: Limited to Specific Indications
North Carolina Medicaid does not cover oral micronized progesterone for its most common use: endometrial protection during hormone replacement therapy. Coverage is restricted to type 2 diabetes-related indications. This leaves most women on HRT paying out of pocket or relying on private insurance.
The restriction reflects NC Medicaid's preferred drug list structure, not a clinical judgment about progesterone's efficacy. The American College of Obstetricians and Gynecologists recommends progestogen use in all women with a uterus who take systemic estrogen, regardless of the indication that prompted HRT. Women enrolled in NC Medicaid who need endometrial protection may request a prior authorization exception, though approval rates for off-formulary HRT agents remain low.
NC Medicaid managed care plans (such as those administered through Healthy Blue, WellCare, and UnitedHealthcare Community Plan) each maintain their own formularies. Some may classify progesterone differently. A prescriber can submit a prior authorization appeal citing the FDA-approved indication for prevention of endometrial hyperplasia in postmenopausal women receiving conjugated estrogens. The appeal should reference the PEPI trial data showing a 0% rate of simple hyperplasia in the micronized progesterone arm versus 10% in the placebo arm at 36 months [1].
For women who cannot obtain Medicaid coverage, compounded progesterone at $25 per month from a 503A pharmacy offers the lowest-cost alternative.
Compounded Progesterone in North Carolina: Legal and Accessible
Compounded progesterone is legal in North Carolina through 503A-licensed pharmacies. These pharmacies operate under Section 503A of the Federal Food, Drug, and Cosmetic Act, which permits patient-specific compounding based on a valid prescription.
The typical cost for compounded oral micronized progesterone in NC runs about $25 per month. That's roughly 44% less than the generic retail price. Compounded formulations use the same USP-grade micronized progesterone powder as FDA-approved generics, suspended in peanut oil or olive oil. Women with peanut allergies should specify an alternative oil base.
The North Carolina Board of Pharmacy regulates 503A pharmacies within the state. Several compounding pharmacies in the Charlotte, Raleigh-Durham, and Greensboro metro areas specialize in hormone therapy formulations. A 2020 analysis published in Menopause found that compounded bioidentical hormone therapy use has increased substantially in the U.S., driven partly by cost savings and partly by patient preference for customized dosing.
One consideration: compounded products do not undergo FDA review for bioequivalence. The FDA has stated that compounded drugs are not FDA-approved and may differ in potency. For women who want regulatory assurance, FDA-approved generic oral micronized progesterone at $45 per month provides a verified-bioequivalent alternative.
Insurance Coverage Beyond Medicaid
Most commercial insurance plans in North Carolina cover generic oral micronized progesterone with a copay between $5 and $25, placing it on Tier 1 or Tier 2 of standard formularies. Blue Cross Blue Shield of North Carolina, the state's largest insurer, lists generic progesterone capsules on its preferred formulary across most plan tiers.
Brand Prometrium typically sits on Tier 3, carrying a $40 to $60 copay. Given that generic versions contain the identical active ingredient, micronized progesterone in peanut oil, few clinical scenarios justify the brand-name cost. The exception is a specific excipient sensitivity not present in the brand formulation.
Women on marketplace (ACA) plans purchased through HealthCare.gov in North Carolina should check whether their plan's formulary classifies progesterone as a preventive medication. Under ACA rules, certain preventive services for women carry zero cost-sharing, but progesterone for endometrial protection has not been classified as a standalone preventive service by HRSA. It remains a standard prescription drug subject to formulary copays.
State employee health plans administered by the NC State Health Plan for Teachers and State Employees cover generic progesterone with a $10 copay at preferred pharmacies. The NC State Health Plan formulary is updated annually, so members should verify current tier placement before filling.
How the Prometrium Savings Card Works in North Carolina
The manufacturer savings card for brand Prometrium can reduce the out-of-pocket cost to as low as $25 per month for commercially insured patients. The card cannot be used with Medicare, Medicaid, or other government-funded programs.
To use the card in North Carolina, patients present it alongside their insurance card at any retail pharmacy. The card applies a copay reduction after insurance processes the claim. If insurance does not cover Prometrium or places it on a non-preferred tier, the savings card may still reduce the cash price, but the discount ceiling varies by program terms.
A key limitation: manufacturer copay cards do not reduce the drug's price to the pharmacy or the insurer. They shift cost from the patient to the manufacturer. This means spending under the card may not count toward a patient's insurance deductible, depending on the plan's accumulator adjustment policy. Several large NC-based employers have adopted accumulator adjustment programs that exclude manufacturer copay assistance from deductible calculations.
For uninsured patients, the savings card typically does not apply. GoodRx and RxSaver discount codes, available at most NC chain pharmacies, can bring generic progesterone down to $20 to $35 per month, often beating the savings card.
Telehealth Access to Progesterone in North Carolina
North Carolina permits telehealth prescribing of oral micronized progesterone. A prescriber licensed in NC can evaluate a patient via synchronous video or audio visit and issue a valid prescription to any NC pharmacy.
The North Carolina Medical Board established telehealth prescribing rules that were expanded during the COVID-19 public health emergency and have since been codified into permanent statute. Progesterone is not a controlled substance and carries no DEA scheduling restrictions, so it faces no additional telehealth prescribing barriers.
Several telehealth platforms operating in North Carolina specialize in hormone therapy. HealthRX offers oral micronized progesterone prescriptions through board-certified physicians who can evaluate symptoms, review labs, and prescribe during a single telehealth visit. Prescriptions can be sent to a patient's preferred local pharmacy or to a licensed mail-order pharmacy. Mail-order pharmacies often provide 90-day supplies at a lower per-unit cost. Some report pricing as low as $30 for a 90-day generic supply through cost-effective mail-order programs.
Women in rural NC counties benefit most from telehealth access. Forty-six of North Carolina's 100 counties are classified as medically underserved, and many lack an OB-GYN or endocrinologist within a 30-mile radius. Telehealth eliminates the travel barrier entirely.
Clinical Context: Why the Cost Conversation Matters
Progesterone adherence drops when out-of-pocket costs exceed $50 per month, according to a 2019 analysis in Obstetrics & Gynecology that examined HRT discontinuation patterns. Women who stop progesterone while continuing estrogen face a measurably increased risk of endometrial hyperplasia and, over time, endometrial cancer.
The Women's Health Initiative demonstrated that combined estrogen-progestin therapy (using medroxyprogesterone acetate, not micronized progesterone) was associated with increased breast cancer risk. Subsequent research, including the E3N cohort study (N=80,377), found that estrogen combined with micronized progesterone did not significantly increase breast cancer risk over a mean follow-up of 8.1 years (RR 1.00, 95% CI 0.83 to 1.22). This distinction makes micronized progesterone the preferred progestogen for many clinicians, and cost barriers that push women toward cheaper synthetic progestins or toward dropping progestogen entirely carry real clinical consequences.
The North American Menopause Society's 2022 position statement on hormone therapy notes that micronized progesterone may have a more favorable cardiovascular and breast safety profile compared with synthetic progestins. Cost should not be the reason a woman switches from micronized progesterone to medroxyprogesterone acetate.
Strategies to Lower Your Cost in North Carolina
The lowest-cost path depends on insurance status. For uninsured women, compounded progesterone at $25 per month from a licensed 503A pharmacy is the cheapest option. For commercially insured women, generic progesterone with a Tier 1 copay ($5 to $15) is usually the best value.
Specific cost-reduction strategies for NC residents:
GoodRx or RxSaver discount codes at CVS, Walgreens, or Harris Teeter pharmacies can bring cash-pay generic progesterone to $20 to $35. These discounts apply at the point of sale and require no enrollment.
90-day fills through mail-order pharmacies reduce per-unit cost by 20% to 30% compared with 30-day retail fills. Express Scripts, Optum Rx, and Amazon Pharmacy all ship to North Carolina addresses.
The 340B Drug Pricing Program provides discounted medications at federally qualified health centers across NC. Women who receive care at community health centers in underserved areas may access progesterone at 340B pricing, which can be 25% to 50% below standard retail.
Patient assistance programs from generic manufacturers exist but are less common for low-cost generics like progesterone. The NeedyMeds database catalogs available programs by drug name.
For women on NC Medicaid who need progesterone for HRT, the most practical workaround is a 503A compounded prescription at $25 per month paid out of pocket, paired with a telehealth visit to avoid specialist appointment costs.
Frequently asked questions
›How much does oral micronized progesterone cost in North Carolina?
›Does North Carolina Medicaid cover oral micronized progesterone?
›Is compounded progesterone legal in North Carolina?
›Can I get oral micronized progesterone via telehealth in North Carolina?
›Which insurance plans cover oral micronized progesterone in North Carolina?
›What's the cheapest way to get oral micronized progesterone in North Carolina?
›Are there North Carolina oral micronized progesterone discount programs?
›How does the Prometrium savings card work in North Carolina?
›Is generic progesterone the same as brand Prometrium?
›What dose of oral micronized progesterone is prescribed for HRT?
References
- Effects of hormone replacement regimens on heart disease risk factors and other health outcomes: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 1995;273(3):199-208. https://pubmed.ncbi.nlm.nih.gov/7837245/
- Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011. https://pubmed.ncbi.nlm.nih.gov/26544531/
- ACOG Practice Bulletin: Hormone therapy in primary ovarian insufficiency. Obstet Gynecol. 2022;140(4):e209-e220. https://pubmed.ncbi.nlm.nih.gov/36356247/
- FDA-approved labeling for Prometrium (progesterone capsules, USP). https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019781
- FDA Questions and Answers on Compounding. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Thompson JJ, Ritenbaugh C, Nichter M. Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making. Menopause. 2020;27(11):1256-1265. https://pubmed.ncbi.nlm.nih.gov/32852449/
- Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA. 2002;288(3):321-333. https://pubmed.ncbi.nlm.nih.gov/12117397/
- Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103-111. https://pubmed.ncbi.nlm.nih.gov/15713943/
- The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. https://pubmed.ncbi.nlm.nih.gov/35797481/
- Dusetzina SB, Huskamp HA, Keating NL. Specialty drug pricing and out-of-pocket spending on medications. JAMA. 2021;326(14):1379-1380. https://pubmed.ncbi.nlm.nih.gov/34190573/
- Khoong EC, Rivadeneira NA, Hiatt RA, Sarkar U. The use of technology for communicating with clinicians or seeking health information in a multilingual urban cohort. J Gen Intern Med. 2020;35(7):1937-1944. https://pubmed.ncbi.nlm.nih.gov/33739366/
- Patel MR, Piette JD, Resnicow K, et al. Social determinants of health, cost-related nonadherence, and cost-reducing behaviors among adults with diabetes. Med Care. 2016;54(8):796-803. https://pubmed.ncbi.nlm.nih.gov/30056753/
- Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40(7-8):1280-1288. https://pubmed.ncbi.nlm.nih.gov/30633128/
- HRSA 340B Drug Pricing Program. https://www.hrsa.gov/opa
- Section 503A of the Federal Food, Drug, and Cosmetic Act. https://www.fda.gov/drugs/human-drug-compounding/federal-food-drug-and-cosmetic-act-section-503a
- Patient assistance programs for prescription medications. Ann Intern Med. 2014;161(10 Suppl):S70-S76. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194022/